Skip to main navigation Skip to search Skip to main content

The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)4950-4956
Number of pages7
JournalClinical Cancer Research
Volume6
Issue number12
StatePublished - Dec 2000
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • Neoplasm Transplantation
  • Antineoplastic Agents/administration & dosage
  • Prednisolone/administration & dosage
  • Bryostatins
  • Humans
  • Vincristine/administration & dosage
  • Protein Kinase C/metabolism
  • Flow Cytometry
  • Time Factors
  • Proto-Oncogene Proteins c-bcl-2/biosynthesis
  • Tumor Cells, Cultured
  • Antineoplastic Combined Chemotherapy Protocols/administration & dosage
  • Macrolides
  • Proto-Oncogene Proteins/biosynthesis
  • Apoptosis/drug effects
  • bcl-2-Associated X Protein
  • Mice, SCID
  • Blotting, Western
  • Lactones/administration & dosage
  • Animals
  • Cyclophosphamide/administration & dosage
  • Lymphoma, Large B-Cell, Diffuse/drug therapy
  • Doxorubicin/administration & dosage
  • Mice
  • Enzyme Activation
  • Poly(ADP-ribose) Polymerases/biosynthesis

Cite this